PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer
Abstract 5-Fluorouracil (5-FU) resistance remains a significant challenge in the treatment of gastric cancer, limiting its clinical efficacy. Our study identifies NUSAP1, a nucleolar and spindle-associated protein, as a key driver of 5-FU resistance in gastric cancer. Proteomic analyses of 5-FU-resi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07723-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327795063226368 |
|---|---|
| author | Suting Jiang Guoli Li Shihan Peng Shitong Chen Yi Pang Hongjuan Cui Feng Wang |
| author_facet | Suting Jiang Guoli Li Shihan Peng Shitong Chen Yi Pang Hongjuan Cui Feng Wang |
| author_sort | Suting Jiang |
| collection | DOAJ |
| description | Abstract 5-Fluorouracil (5-FU) resistance remains a significant challenge in the treatment of gastric cancer, limiting its clinical efficacy. Our study identifies NUSAP1, a nucleolar and spindle-associated protein, as a key driver of 5-FU resistance in gastric cancer. Proteomic analyses of 5-FU-resistant gastric cancer cell lines revealed that NUSAP1 is significantly upregulated, and functional studies demonstrated its essential role in promoting resistance, proliferation, migration, invasion, and tumor growth. Mechanistic investigations revealed that NUSAP1 undergoes asymmetric dimethylation (ADMA) at R418 and R422, mediated by PRMT1, with the R422 site being critical for its function. NUSAP1 interacts with the PEST domain of Notch2 through its R422 site, inhibiting Notch2 ubiquitination and stabilizing its expression, thereby activating the Notch2 signaling pathway. This pathway is closely linked to gastric cancer progression and chemoresistance. Inhibition of PRMT1 or mutation of the R422 site abrogated NUSAP1’s ability to stabilize Notch2 and regulate downstream signaling. These findings unveil a novel mechanism by which NUSAP1 promotes 5-FU resistance in gastric cancer and highlight the therapeutic potential of targeting the NUSAP1-Notch2 axis or PRMT1 in overcoming chemoresistance. |
| format | Article |
| id | doaj-art-fdc19c4da75749dd90e9f236c6b8d767 |
| institution | Kabale University |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-fdc19c4da75749dd90e9f236c6b8d7672025-08-20T03:47:45ZengNature Publishing GroupCell Death and Disease2041-48892025-05-0116111410.1038/s41419-025-07723-9PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancerSuting Jiang0Guoli Li1Shihan Peng2Shitong Chen3Yi Pang4Hongjuan Cui5Feng Wang6Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing Three Gorges Medical CollegeChongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing Three Gorges Medical CollegeState Key Laboratory of Resource Insects, Medical Research Institute, Southwest UniversityState Key Laboratory of Resource Insects, Medical Research Institute, Southwest UniversityChongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing Three Gorges Medical CollegeState Key Laboratory of Resource Insects, Medical Research Institute, Southwest UniversityChongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing Three Gorges Medical CollegeAbstract 5-Fluorouracil (5-FU) resistance remains a significant challenge in the treatment of gastric cancer, limiting its clinical efficacy. Our study identifies NUSAP1, a nucleolar and spindle-associated protein, as a key driver of 5-FU resistance in gastric cancer. Proteomic analyses of 5-FU-resistant gastric cancer cell lines revealed that NUSAP1 is significantly upregulated, and functional studies demonstrated its essential role in promoting resistance, proliferation, migration, invasion, and tumor growth. Mechanistic investigations revealed that NUSAP1 undergoes asymmetric dimethylation (ADMA) at R418 and R422, mediated by PRMT1, with the R422 site being critical for its function. NUSAP1 interacts with the PEST domain of Notch2 through its R422 site, inhibiting Notch2 ubiquitination and stabilizing its expression, thereby activating the Notch2 signaling pathway. This pathway is closely linked to gastric cancer progression and chemoresistance. Inhibition of PRMT1 or mutation of the R422 site abrogated NUSAP1’s ability to stabilize Notch2 and regulate downstream signaling. These findings unveil a novel mechanism by which NUSAP1 promotes 5-FU resistance in gastric cancer and highlight the therapeutic potential of targeting the NUSAP1-Notch2 axis or PRMT1 in overcoming chemoresistance.https://doi.org/10.1038/s41419-025-07723-9 |
| spellingShingle | Suting Jiang Guoli Li Shihan Peng Shitong Chen Yi Pang Hongjuan Cui Feng Wang PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer Cell Death and Disease |
| title | PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer |
| title_full | PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer |
| title_fullStr | PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer |
| title_full_unstemmed | PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer |
| title_short | PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer |
| title_sort | prmt1 catalyzed nusap1 methylation enhances notch2 signaling and 5 fu resistance in gastric cancer |
| url | https://doi.org/10.1038/s41419-025-07723-9 |
| work_keys_str_mv | AT sutingjiang prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer AT guolili prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer AT shihanpeng prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer AT shitongchen prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer AT yipang prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer AT hongjuancui prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer AT fengwang prmt1catalyzednusap1methylationenhancesnotch2signalingand5furesistanceingastriccancer |